Clariness acquires Viomedo
Stefan and I have founded Viomedo with the goal to democratize access to clinical trials for all patients and significantly accelerate clinical development. Since 2015, together with our incredible team, we have made the first few steps along the way. During that time, we have created the leading online clinical trials platform in the German-speaking region, supported thousands of patients and dozens of trials. And we are just getting started.
Now, all of us are excited to join Clariness to accelerate our joint vision to empower patients and researchers all over the world. Viomedo will keep operating as a separate entity within Clariness. Together we are committed to providing our clients with the best combination of global coverage and deep localized services in the key markets. We will keep on driving innovation and making a difference in clinical trials with our effective patient recruitment and retention solutions as well as innovative products for study feasibility and planning and more.
And read the complete press release here.